Subvariants BQ.1.1 and BQ.1 are now dominant in the U.S.

Subvariants BQ.1.1 and BQ.1 are now dominant in the U.S.

The FDA has pulled the plug on the COVID-19 drug bebtelovimab, which may not work against the two variants.

TRACKING COVID IN THE U.S.